ETS1 and neoplasm: The results of the CCK-8 assay indicate that the proliferation rate of tumor cell lines was significantly lower than that of normal cell lines (Figure 5), indicating that the Ets-1-sensitive CRISPReader system can effectively inhibit the proliferation of different tumor cells and has broad-spectrum anti-tumor activity.